Is it true that the targeted drug pemetinib/pemetinib will be free for life after paying 100,000 out of pocket?

The targeted drug pemigatinib/Pemigatinib(Pemigatinib)At your own expenseIt is not accurate to say that after 100,000 yuan, it will be free for life. Usually, the price and cost of drugs are determined by a variety of factors, including drug research and development costs, production costs, market demand, medical insurance policies, etc. Therefore, there is no universally applicable "free for life after spending 100,000 yuan" policy.

Pemetinib is suitable for the treatment of patients with fibroblast growth factor receptor2 (FGFR2) unresectable locally advanced or metastatic cholangiocarcinoma in adult patients treated with fusion or other FDA-approved rearrangements; also indicated for the treatment of adults with relapsed or refractory myeloid/lymphoid neoplasms (MLNs) with FGFR1 rearrangements. For targeted drugs like pemetinib, the price may be higher, and some patients may need to bear greater financial pressure. There are 4.5mg*14 tablets, 9mg*14 tabletsTwo kinds ofspecificationsThe price of each box may be 30,000 to 50,000 yuan.

In order to ease the financial burden on patients, some hospitals or charities may launch some preferential policies or assistance projects, such as providing drug discounts, exempting some fees, setting up charitable funds, etc. However, these policies and programs are usually limited, and specific implementation details and application conditions vary from institution to institution. Therefore, patients should rationally choose drugs and treatment plans based on their own financial situation and condition needs, and avoid blindly following trends or listening to false rumors. Finally, it needs to be emphasized that the use of any medicine needs to be under the guidance of a doctor. Patients should strictly follow the doctor's instructions and do not buy or use medicines privately to avoid unnecessary risks to treatment.